NO161068C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 7beta-((z)-2-2-aminothiazol-4-yl)-2-oxyimino-ace-tamido)-3-cefem-4-carboxylsyreforbindelser. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive 7beta-((z)-2-2-aminothiazol-4-yl)-2-oxyimino-ace-tamido)-3-cefem-4-carboxylsyreforbindelser.

Info

Publication number
NO161068C
NO161068C NO832828A NO832828A NO161068C NO 161068 C NO161068 C NO 161068C NO 832828 A NO832828 A NO 832828A NO 832828 A NO832828 A NO 832828A NO 161068 C NO161068 C NO 161068C
Authority
NO
Norway
Prior art keywords
preparation
tamido
7beta
cefem
aminothiazol
Prior art date
Application number
NO832828A
Other languages
English (en)
Norwegian (no)
Other versions
NO161068B (no
NO832828L (no
Inventor
Toyonari Oine
Hiroshi Sugano
Yoshihisa Yamada
Totaro Yamaguchi
Satoshi Ohshima
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of NO832828L publication Critical patent/NO832828L/no
Publication of NO161068B publication Critical patent/NO161068B/no
Publication of NO161068C publication Critical patent/NO161068C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
NO832828A 1982-08-07 1983-08-05 Analogifremgangsmaate for fremstilling av terapeutisk aktive 7beta-((z)-2-2-aminothiazol-4-yl)-2-oxyimino-ace-tamido)-3-cefem-4-carboxylsyreforbindelser. NO161068C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8222823 1982-08-07

Publications (3)

Publication Number Publication Date
NO832828L NO832828L (no) 1984-02-08
NO161068B NO161068B (no) 1989-03-20
NO161068C true NO161068C (no) 1989-06-28

Family

ID=10532181

Family Applications (1)

Application Number Title Priority Date Filing Date
NO832828A NO161068C (no) 1982-08-07 1983-08-05 Analogifremgangsmaate for fremstilling av terapeutisk aktive 7beta-((z)-2-2-aminothiazol-4-yl)-2-oxyimino-ace-tamido)-3-cefem-4-carboxylsyreforbindelser.

Country Status (23)

Country Link
US (4) US4598075A (fi)
EP (2) EP0101265B1 (fi)
JP (3) JPS5951292A (fi)
KR (1) KR870001440B1 (fi)
AT (2) ATE35413T1 (fi)
AU (1) AU562248B2 (fi)
BG (3) BG40967A3 (fi)
CA (1) CA1231940A (fi)
CS (2) CS243484B2 (fi)
DD (1) DD210053A5 (fi)
DE (2) DE3377213D1 (fi)
DK (2) DK358983A (fi)
ES (3) ES8502121A1 (fi)
FI (1) FI74972C (fi)
GR (1) GR78864B (fi)
IE (1) IE55406B1 (fi)
IL (1) IL69246A (fi)
NO (1) NO161068C (fi)
PH (1) PH18498A (fi)
PL (2) PL140023B1 (fi)
PT (1) PT77166B (fi)
SU (2) SU1227116A3 (fi)
ZA (1) ZA835411B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL69246A (en) * 1982-08-07 1986-07-31 Tanabe Seiyaku Co 7-((2-aminothiazolyl-2-pyrrolidonyl or(piperidonyl)-oxyimino)acetamido)cephem carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
JPS60132983A (ja) * 1983-12-21 1985-07-16 Tanabe Seiyaku Co Ltd チアゾ−ル酢酸誘導体及びその製法
JPS6178792A (ja) * 1984-09-26 1986-04-22 Yamanouchi Pharmaceut Co Ltd 7−〔α−(2−アミノ−4−チアゾリル)−α−(4−オキソ−2−アゼチジニル置換イミノ)アセトアミド〕−3−置換メチル−Δ↑3−セフエム−4−カルボン酸およびその製造法
JPS6185392A (ja) * 1984-10-03 1986-04-30 Tanabe Seiyaku Co Ltd セフアロスポリン化合物の新規製法
JPS61143379A (ja) * 1984-12-14 1986-07-01 Tanabe Seiyaku Co Ltd チアゾ−ル酢酸誘導体の製法
JPS61143380A (ja) * 1984-12-14 1986-07-01 Tanabe Seiyaku Co Ltd チアゾ−ル酢酸誘導体の製法
JPS61143381A (ja) * 1984-12-14 1986-07-01 Tanabe Seiyaku Co Ltd 光学活性チアゾ−ル酢酸誘導体の製法
CA1263399A (en) * 1984-12-19 1989-11-28 Hoffmann-La Roche Limited Process for the manufacture of aminothiazole acetic acid derivatives
JPS61171464A (ja) * 1985-01-23 1986-08-02 Dai Ichi Seiyaku Co Ltd オキシイミノ酪酸誘導体の製法
JPS63107989A (ja) * 1986-06-04 1988-05-12 Tanabe Seiyaku Co Ltd セファロスポリン化合物
IL82738A0 (en) * 1986-06-16 1987-12-20 Tanabe Seiyaku Co Cephalosporin compounds,their preparation and pharmaceutical compositions containing them
AT389701B (de) * 1987-10-08 1990-01-25 Tanabe Seiyaku Co Neue cephalosporinverbindungen und diese enthaltende pharmazeutische zusammensetzungen
JP4773154B2 (ja) * 2005-07-29 2011-09-14 小澤物産株式会社 レバー式カップリング

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
GB1536281A (en) * 1975-06-09 1978-12-20 Takeda Chemical Industries Ltd Cephem compounds
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
IE44888B1 (en) * 1976-03-09 1982-05-05 Fujisawa Pharmaceutical Co 3,7-disubstituted-3-cephem-4-carboxylic acid compounds and processes for the preparation theroef
DE2715385A1 (de) * 1976-04-14 1977-11-10 Takeda Chemical Industries Ltd Cephalosporinderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
FR2384782A1 (fr) * 1977-03-25 1978-10-20 Roussel Uclaf Nouvelles oximes derivees de l'acide 3-acetoxymethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
SE448379B (sv) * 1978-03-31 1987-02-16 Roussel Uclaf O-substituerade oximderivat av 7-amino-tiazolyl-acetamidocefalosporansyra
AR228726A1 (es) * 1978-05-26 1983-04-15 Glaxo Group Ltd Procedimiento para la preparacion del antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)acetamido)-3-(1-piridiniometil)cef-3-em-4-carboxilato
EP0009548B1 (en) * 1978-07-17 1985-01-16 Fujisawa Pharmaceutical Co., Ltd. Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them
US4284631A (en) * 1978-07-31 1981-08-18 Fujisawa Pharmaceutical Co., Ltd. 7-Substituted cephem compounds and pharmaceutical antibacterial compositions containing them
GB2028305A (en) * 1978-08-03 1980-03-05 Hoechst Ag Cephem derivatives and processes for their manufacture
US4271157A (en) * 1980-02-28 1981-06-02 E. R. Squibb & Sons, Inc. Imidazole derivatives of 7-[(2-amino-4-thiazolyl)-oximino] cephalosporins
GB2061276B (en) * 1979-10-25 1983-05-25 Squibb & Sons Inc Imidazole and tetrazole derivatives of 7-((2-amino-4-thiazolyl)-oximino)cephalosporins
US4416879A (en) * 1980-09-08 1983-11-22 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
IL69246A (en) * 1982-08-07 1986-07-31 Tanabe Seiyaku Co 7-((2-aminothiazolyl-2-pyrrolidonyl or(piperidonyl)-oxyimino)acetamido)cephem carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
JPS59155391A (ja) * 1983-02-22 1984-09-04 Tanabe Seiyaku Co Ltd 新規セファロスポリン誘導体

Also Published As

Publication number Publication date
DK361587A (da) 1987-07-10
PT77166A (en) 1983-09-01
PT77166B (pt) 1986-01-28
ES8506707A1 (es) 1985-08-01
JPS62294615A (ja) 1987-12-22
NO161068B (no) 1989-03-20
AU562248B2 (en) 1987-06-04
PL140023B1 (en) 1987-03-31
EP0245619B1 (en) 1990-07-11
PL243329A1 (en) 1985-02-13
ES535281A0 (es) 1985-12-16
BG37838A3 (en) 1985-08-15
JPH0145473B2 (fi) 1989-10-03
CS236798B2 (en) 1985-05-15
IE831648L (en) 1984-02-07
PL249964A1 (en) 1985-05-07
ATE54450T1 (de) 1990-07-15
ES531296A0 (es) 1985-08-01
JPS62294681A (ja) 1987-12-22
PH18498A (en) 1985-08-02
DK358983D0 (da) 1983-08-05
IL69246A (en) 1986-07-31
GR78864B (fi) 1984-10-02
ATE35413T1 (de) 1988-07-15
KR840005816A (ko) 1984-11-19
EP0101265A3 (en) 1985-04-10
US4727071A (en) 1988-02-23
BG42835A3 (en) 1988-02-15
EP0101265A2 (en) 1984-02-22
CS243484B2 (en) 1986-06-12
NO832828L (no) 1984-02-08
FI74972B (fi) 1987-12-31
CS196483A2 (en) 1985-08-22
JPH0246588B2 (fi) 1990-10-16
JPH0360803B2 (fi) 1991-09-17
DK361587D0 (da) 1987-07-10
IL69246A0 (en) 1983-11-30
EP0245619A1 (en) 1987-11-19
CA1231940A (en) 1988-01-26
SU1227116A3 (ru) 1986-04-23
ES524775A0 (es) 1984-12-16
PL139932B1 (en) 1987-03-31
DE3381734D1 (de) 1990-08-16
KR870001440B1 (ko) 1987-08-06
AU1710483A (en) 1984-02-09
JPS5951292A (ja) 1984-03-24
FI74972C (fi) 1988-04-11
SU1324586A3 (ru) 1987-07-15
US4598075A (en) 1986-07-01
US4598154A (en) 1986-07-01
DE3377213D1 (en) 1988-08-04
FI832770A0 (fi) 1983-08-02
FI832770A (fi) 1984-02-08
DK358983A (da) 1984-02-08
BG40967A3 (en) 1987-03-14
US4742174A (en) 1988-05-03
ES8603496A1 (es) 1985-12-16
ES8502121A1 (es) 1984-12-16
DD210053A5 (de) 1984-05-30
IE55406B1 (en) 1990-09-12
ZA835411B (en) 1984-03-28
EP0101265B1 (en) 1988-06-29

Similar Documents

Publication Publication Date Title
DZ863A1 (fr) Dérivés de benzoxazol et benzothiazolamine.
NO161068C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 7beta-((z)-2-2-aminothiazol-4-yl)-2-oxyimino-ace-tamido)-3-cefem-4-carboxylsyreforbindelser.
PT87277A (pt) Process for the preparation of new bicyclic compounds and pharmaceutical compositions comprising same
NO158379C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nitroalifatiske forbindelser.
DK183789A (da) 2-alkyl-3-benzoylbenzofuraner og laegemidler indeholdende disse
ES2054653T3 (es) Un procedimiento para preparar un compuesto quimico.
SE7907689L (sv) Nya hydroxamsyraforeningar, sett for deras framstellning samt anvendning av dessa foreningar som lekemedel
DE3362523D1 (en) Optically active imidazolylpropanol compounds, and their production and use
JPS5589257A (en) New easily-absorbable sulfur-containing prodrug of non- steroidal antiphlogistic, and their drug compositions
IE801364L (en) Clavulanic acid derivatives